You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • SAT0164 Immune Reconstitution 20 Years after Treatment with Alemtuzumab in A Rheumatoid Arthritis Cohort: Implications for Lymphocyte Depleting Therapies

Alerts

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0164 Immune Reconstitution 20 Years after Treatment with Alemtuzumab in A Rheumatoid Arthritis Cohort: Implications for Lymphocyte Depleting Therapies
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address